Precise Health
Precise Health is a Swiss AI-powered phage therapy platform that enables clinicians to rapidly match, source, and engineer bacteriophages for multidrug-resistant infections, connecting global phage banks, hospitals, patients, researchers, and biopharma through a unified digital phagogram.
- Company typePrivate
- Founded2023
- HeadquartersSion, Switzerland
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Precise Health does
Precise Health is a Swiss-based, privately held health technology company founded in 2023 that operates an AI-powered phage therapy platform designed to combat antimicrobial resistance (AMR). The platform enables licensed clinicians and hospitals to identify, source, and engineer bacteriophages for treating multidrug-resistant bacterial infections, reducing treatment timelines from months to days. Precise Health serves four stakeholder groups: clinicians and hospitals (primary commercial segment), patients and caregivers, researchers, and biopharma/biotech/diagnostics companies, connecting them through what the company describes as the first "digital phagogram."
Precise Health firmographics
Firmographics- Name
- Precise Health
- Legal name
- Precise Health
- Website
- https://precisehealth.io
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Precise Health is a Swiss AI-powered phage therapy platform that enables clinicians to rapidly match, source, and engineer bacteriophages for multidrug-resistant infections, connecting global phage banks, hospitals, patients, researchers, and biopharma through a unified digital phagogram.
- Ownership category
- akta.pro rank
Precise Health industry classification
Industry- Product category
- Phage Therapy Platform
- NAICS
- Computer Systems Design and Related Services (5415)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Phage & Phage-Derived Microbiome Modulators (HLAAAFAF)
- akta.pro secondary industry
- Diagnostic & Triage Decision Support (HLACAGAA)
Keywords
Where Precise Health is headquartered
LocationHeadquarters
- HQ city
- Sion
- HQ country
- Switzerland
- HQ region
- Europe
Offices2 records
Markets served
Precise Health business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Platform access and phage matching services: Clinicians and hospitals access the platform to match, source, and engineer phages for treating multidrug-resistant infections. The platform connects phage banks globally and enables prescription-to-treatment in days. Revenue likely derives from subscription or per-case fees from institutional clinical buyers.
- Bio Pharma partnerships: Pharmaceutical, biotech, and diagnostic companies are engaged to accelerate precision antimicrobial development through the platform. Revenue may come from platform licensing, data services, or co-development arrangements with biopharma partners.
- Phage engineering services: PhageTailor™ provides AI-driven in silico phage engineering for complex pan-drug-resistant cases. Engineered phages are prepared by partner labs, suggesting a service revenue component for custom phage design and engineering.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels4 records
Precise Health product offering
Product offeringCore offering
Precise Health operates an AI-powered phage therapy platform that enables clinicians to rapidly identify, source, and engineer bacteriophages for treating multidrug-resistant bacterial infections. The platform connects global Phage Banks in a single digital phagogram, offering instant bacteria-phage matching (PhageMatch™), customized in silico phage engineering (PhageTailor™), and access to over 4,000 pre-selected phages, reducing treatment timelines from months to days.
Product overview
Precise Health offers a unified AI-powered phage therapy platform designed to combat multidrug-resistant infections. The platform operates as a three-pillar architecture: Phage API Collections (access to over 4,000 unique phages stored in global biobanks), PhageMatch™ (instant AI-powered bacteria-phage matching in minutes), and PhageTailor™ (AI-driven customized phage engineering for complex cases). The platform connects clinicians, patients, Phage Banks, and BioPharma companies in a single digital phagogram, enabling treatment from prescription to delivery in days rather than months.
Differentiator
Problem solved
Functional benefit
Brands
- PhageTailor™: Proprietary AI-driven phage engineering engine that designs customized phages based on a patient's bacterial genome. Ideal for non-urgent, pan-drug-resistant infections.
- PhageMatch™
- Phage API Collection
Products and services
- PhageMatch™
Quantifiable outcome
- Treatment timeline reduced from months to days
- +3 more outcomes
Companies that use Precise Health
Customer profileSegments4 records
Ideal customer profiles4 records
Precise Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature4 records
Precise Health partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- Global Phage Banks NetworkcorePrecise Health integrates phage banks across multiple countries into its digital phagogram platform, providing access to a diverse phage API collection. Selected phages are pre-manufactured and securely stored in local and partner biobanks. The company has access to over 4,000 unique phages through these global partnerships.
- Partner Labs (for phage preparation)coreCustomized in-silico engineered phages designed through PhageTailor™ are prepared by partner labs. These labs handle the physical preparation and manufacturing of the AI-designed phage candidates for patient use.
- The Ark Foundation (Sion, Switzerland)minorPrecise Health maintains an office C/O The Ark Foundation at Rue de l'industrie 23, 1950 Sion, Switzerland, indicating a hosting or incubation relationship.
- Startlab@Biopole (Epalinges, Switzerland)minorPrecise Health maintains an office C/O Startlab@Biopole at Rte de la Corniche 5, 1066 Epalinges, Switzerland, indicating a lab space or incubator arrangement at the Biopole biotech campus.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
Precise Health competitors and assessment
Company assessmentEmerging players
- PhagePro: Early-stage phage therapeutics company focused on E. coli and AMR applications. Comparable as a niche emerging player in the broader phage therapy space.
Direct peers
- TechnoPhage: Portuguese biotech developing phage-based therapies for bacterial infections, including respiratory and skin indications. Comparable as a European phage therapy developer with clinical pipeline focus.
- Adaptive Phage Therapeutics: US-based clinical-stage phage therapy company developing personalized phage treatments for multidrug-resistant infections. Directly comparable as a phage therapy platform targeting AMR with curated phage banks and clinical assets.
- Eligo Bioscience: French biotech developing phage-based precision antimicrobials using engineered payloads and synthetic biology. Comparable in combining phage engineering and computational design to address bacterial infections.
- ContraFect: Clinical-stage biopharmaceutical company developing direct lytic agents and anti-infectives for serious drug-resistant infections. Comparable as a therapeutic developer focused exclusively on AMR.
- Armata Pharmaceuticals: Clinical-stage phage therapy company developing engineered phage candidates for antibiotic-resistant infections including respiratory and bloodstream indications. Closely comparable in therapeutic focus on AMR with proprietary phage engineering.
- Locus Biosciences: Developer of engineered phage therapies (crPhage™) targeting antibiotic-resistant bacteria using synthetic biology payloads. Comparable as a phage engineering company applying AI/design tools to address AMR.
- BiomX: Israel-based phage discovery and therapy company with clinical programs targeting AMR and other conditions. Comparable as a phage platform company with proprietary discovery and therapeutic capabilities.
- Pherecydes Pharma: French clinical-stage phage therapy company operating a curated phage bank and providing personalized phage treatments for resistant infections. Comparable in combining a phage bank with AMR clinical focus.
Broad incumbents
- Intralytix: Established US-based phage company producing phage products for food safety, veterinary, and human health applications. Comparable as a broader phage industry incumbent with multiple product lines beyond therapeutics.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Precise Health social profiles
Digital presencePrecise Health compliance and trust
Trust signalCompliance1 record
Precise Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Precise Health leadership team
Management profileNumber of profiles
Profiles10 records
Precise Health funding detail
Funding detailFunding overview
Funding rounds3 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Precise Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Precise Health
What does Precise Health do?
Precise Health operates an AI-powered phage therapy platform that enables clinicians to rapidly identify, source, and engineer bacteriophages for treating multidrug-resistant bacterial infections. The platform connects global Phage Banks in a single digital phagogram, offering instant bacteria-phage matching (PhageMatch™), customized in silico phage engineering (PhageTailor™), and access to over 4,000 pre-selected phages, reducing treatment timelines from months to days.
Is Precise Health a public or private company?
Precise Health is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Precise Health founded?
Precise Health was founded in 2023. It employs 1 to 10 people.
Where is Precise Health based?
Precise Health is headquartered in Sion, Switzerland, in the Europe region.
How does Precise Health make money?
Three revenue lines are on record. Platform access and phage matching services are the primary driver. The others are bio Pharma partnerships and phage engineering services.
Who are Precise Health's main competitors?
PhagePro is listed as an emerging player. Direct peers are TechnoPhage, Adaptive Phage Therapeutics, Eligo Bioscience, ContraFect, Armata Pharmaceuticals, Locus Biosciences, BiomX and Pherecydes Pharma. Intralytix is listed as a broad incumbent.
Does Precise Health have an API?
No public API is recorded for Precise Health.
What industry is Precise Health in?
Precise Health's product category is Phage Therapy Platform. Its primary akta.pro industry code is HLAAAFAF, Phage & Phage-Derived Microbiome Modulators, with a secondary code of HLACAGAA, Diagnostic & Triage Decision Support. Its NAICS code is 5415 and its SIC code is 7372.